Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome
Journal of Clinical Medicine · 02.02.2026 · 15 (3) · 1152
DOI: 10.3390/jcm15031152 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 02.02.2026. Verfasst von Roman Maslennikov und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Moscow 119435, Russia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Many probiotic strains have been studied in relation to irritable bowel syndrome (IBS). The aim of this study was to identify probiotic strains demonstrating efficacy in the management of IBS based on meta-analyses of randomized placebo-controlled trials (RPCTs).
Methods
This systematic review was registered in the PROSPERO database (CRD420251047092). Searches were conducted in PubMed and Scopus on 8 April 2025. Additional completed studies with available results were identified through ClinicalTrials.gov. An additional search of the Cochrane Central Register of Controlled Trials (CENTRAL), including records indexed in EMBASE, was conducted in December 2025 and did not identify any additional studies. RPCTs were included if they evaluated single-strain probiotics without additional active components compared with a placebo in patients with IBS. Studies whose results could not be meta-analyzed were excluded.
Results
A total of 2643 records were identified; 32 articles evaluating 10 probiotic strains were included in the meta-analyses. Meta-analyses demonstrated the efficacy of Bifidobacterium longum (formerly Bifidobacterium infantis) 35624, Lactobacillus rhamnosus GG, Lactiplantibacillus plantarum 299v (DSM 9843), Saccharomyces cerevisiae CNCM I-3856, and Bacillus coagulans Unique IS2 (MTCC 5260) in improving key IBS symptoms. Meta-analyses also demonstrated that Bacillus coagulans MTCC 5856 improved quality of life for those with IBS. Conflicting results were observed for Saccharomyces boulardii CNCM I-745. Meta-analyses did not demonstrate the efficacy of Escherichia coli Nissle 1917, Lactobacillus gasseri BNR17, or Lactobacillus casei Shirota.
Conclusions
Several probiotic strains demonstrated efficacy in the treatment of IBS in meta-analyses of RPCTs.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Gastroenterology and Hepatology, Sechenov University, Moscow 119435, Russia.
- Department of Clinical Disciplines, Tyumen State Medical University, Tyumen 625023, Russia.
ORCID-Profile: Roman Maslennikov, Eva Gosteeva
Zitieren
APA
Maslennikov, R., Gosteeva, E., Ananeva, V., Korshunova, L., Kravtsowa, A., Poluektova, E., Ulyanin, A., Sigidaev, A., Kikhasurova, P., & Ivashkin, V. (2026). Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome. Journal of Clinical Medicine, 15(3), 1152. https://doi.org/10.3390/jcm15031152
Vancouver
Maslennikov R, Gosteeva E, Ananeva V, Korshunova L, Kravtsowa A, Poluektova E, et al. Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome. Journal of Clinical Medicine. 2026;15(3):1152. doi:10.3390/jcm15031152
BibTeX
@article{Maslennikov2026,
author = {Maslennikov, Roman and Gosteeva, Eva and Ananeva, Vera and Korshunova, Lada and Kravtsowa, Anastasya and Poluektova, Elena and Ulyanin, Anatoly and Sigidaev, Alexey and Kikhasurova, Patimat and Ivashkin, Vladimir},
title = {Strain-Specific Systematic Review with Meta-Analysis of Probiotics Efficacy in the Treatment of Irritable Bowel Syndrome},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {3},
pages = {1152},
doi = {10.3390/jcm15031152}
}
EUVIMED